SCHEMBL420082

SCHEMBL420082

OCCC(F)(F)C(F)(F)OC(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29512338 0.79 ALDH1A1 (0.30) ALDH1A1
SCHEMBL29469382 0.79 ALDH1A1 (0.30) ALDH1A1
SCHEMBL30357727 0.79 ALDH1A1 (0.30) ALDH1A1
SCHEMBL11349532 0.79
SCHEMBL13019109 0.78
SCHEMBL13847894 0.77
SCHEMBL416725 0.77
SCHEMBL1094381 0.77
SCHEMBL7066620 0.76 ALDH1A1 (0.31) ALDH1A1
SCHEMBL30096031 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215098-B1 FLUOROALKYL SILANES DU PONT (US) 2014-08-20 EP disclosed
US-8501952-B2 Fluoroalkyl silanes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-08-06 US disclosed
US-8420826-B2 Fluoroalkyl silanes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-04-16 US disclosed
US-20120022267-A1 FLUOROALKYL SILANES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-01-26 US disclosed
US-20120022266-A1 FLUOROALKYL SILANES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-01-26 US disclosed
US-8058463-B2 Fluorosilanes E. I. DU PONT DE NEMOURS AND COMPNAY (US) 2011-11-15 US disclosed
EP-2215098-A1 FLUOROALKYL SILANES E. I. du Pont de Nemours and Company (US) 2010-08-11 EP disclosed
WO-2009073595-A1 FLUOROALKYL SILANES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-06-11 WO disclosed
US-20090143598-A1 FLUOROSILANES E.I. DU PONT DE NEMOURS AND COMPANY 2009-06-04 US disclosed
WO-2009067415-A1 PROCESS FOR MAKING A COLOR FILTER E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-05-28 WO disclosed
WO-2009055628-A1 PROCESS AND MATERIALS FOR MAKING CONTAINED LAYERS AND DEVICES MADE WITH SAME E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022267-A1 FLUOROALKYL SILANES QSOX1, FRG1, CYP2F1 ALDH1A1 2074/4885
US-20120022266-A1 FLUOROALKYL SILANES AFF1, FRG1, PFN1 ALDH1A1 1505/4885
US-20090143598-A1 FLUOROSILANES RTN3, FFAR3, SPTLC3 ALDH1A1 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.